503A vs 503B Compounding: What Florida Patients Should Understand

503A and 503B are two federal pathways for compounding, which is making a medicine outside the standard manufacturing and approval process. 503A covers state-licensed pharmacies that compound for individual patient prescriptions. 503B covers registered outsourcing facilities. Neither pathway makes a compounded drug FDA-approved.

What this is / what this is not

What this is: A plain-language explanation of the two federal compounding pathways and what they mean for patients, for Florida adults.

What this is not: A recommendation of any compounded product or pharmacy. This page doesn't name any drug or substance. Not legal advice. Not advice to start, stop, or change any medicine. Not care for anyone outside Florida. Not for emergencies. If you have one, call 911.

Who this may be relevant for

This may be useful if you are a Florida adult who:

• Has been prescribed, or offered, a compounded medicine
• Saw "503A" or "503B" on a label or website and wants to know what it means
• Wants to know what questions to ask before taking a compounded product

It does not diagnose you. Only a licensed clinician, after an evaluation, can say what is appropriate for you.

What compounding is

Compounding means preparing a medicine by combining, mixing, or changing ingredients. It's often used when an approved product doesn't fit a patient's need, for example when someone needs a different form or can't take an ingredient in the standard version. FDA notes that compounded drugs can serve an important medical need. They also carry different risks than approved medicines, which is why the pathway matters.

The names 503A and 503B come from sections of the federal Food, Drug, and Cosmetic Act.

What 503A means

As of October 2026, FDA describes 503A compounding as work done by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician, that is not registered as an outsourcing facility.

In general:

• It's tied to prescriptions for individual patients
• The pharmacy is overseen mainly by its state board of pharmacy
• Bulk ingredients must meet federal rules. FDA says a substance must have an official quality standard (a USP or NF monograph), be part of an FDA-approved drug, or appear on a federal list of approved bulk substances

FDA has an interim policy while that list is being built. It sorts nominated substances into categories, including one for substances that may present significant safety risks. A substance's category can change, so ask your pharmacist or clinician about current status rather than relying on a website.

In October 2026, HHS published a Federal Register notice announcing a separate interim enforcement policy for certain peptide substances. It covers compounding under section 503A, by state-licensed pharmacies, federal facilities, and licensed physicians, while FDA's rulemaking on the 503A list continues. It is not FDA approval.

What 503B means

503B covers outsourcing facilities. These are compounders that register with FDA as outsourcing facilities. As of October 2026, FDA describes them this way:

• They can make larger batches, with or without individual prescriptions
• They're subject to federal manufacturing quality standards and FDA inspection
• Their labels must state "This is a compounded drug"

FDA keeps a public list of registered outsourcing facilities, which includes facilities in Florida. You can check whether a facility is registered there.

Why "compounded" doesn't mean "approved"

This is the single most important point. FDA states that compounded drugs are not FDA-approved. That means the agency does not review their safety, effectiveness, or quality before they are marketed.

That's true for both 503A and 503B. The difference between them is how they're overseen, not whether they're approved. An approved medicine has been through FDA review for a specific use. A compounded one has not, even when it's prepared carefully under the rules.

The Florida angle

In Florida, the Board of Pharmacy sets standards of practice for pharmacies by rule. Florida telehealth is held to the same standard as an in-person visit, so a prescription through telehealth carries the same responsibility as one from an office visit. Our consult-first telehealth post explains more.

Questions to ask your clinician or pharmacist

If a compounded medicine comes up, it's reasonable to ask:

• Is there an FDA-approved option, and why is a compounded one being suggested instead?
• Is this coming from a 503A pharmacy or a 503B outsourcing facility?
• Is the facility licensed in Florida, or registered with FDA if it's 503B?
• What should I watch for, and who do I call if something seems wrong?

One of our licensed clinicians is glad to walk through these questions with you.

Never start, stop, or change a medication or peptide without your prescriber.

What a consult may cover

A consult with one of our licensed clinicians starts with conversation, not a menu. It may cover your health history, medicines and supplements you take, labs when indicated, and whether a compounded option makes sense at all. We can order labs for you, or you can bring recent bloodwork you've already had done. This site has no price menu. Fees, and whether a therapy is right for you, are covered in the consult. For a broader primer, see what are peptides, and how a consult works walks through the steps.

Frequently asked questions

Is a 503B product FDA-approved?
No. 503B facilities are inspected by FDA, but their products are still not FDA-approved.

Is 503A or 503B "better"?
Neither is better across the board. They serve different roles. Your clinician and pharmacist can explain which applies to you.

How do I know if a compounded drug came from a 503B facility?
503B labels must say "This is a compounded drug," and FDA lists registered facilities online.

What if this is an emergency?
Call 911.

A clear next step

This is education, not a treatment plan. A licensed provider decides if care is appropriate.

If you are a Florida adult and want to talk through a compounded medicine in a private consult, request a consult at Book a consult, or call (727) 577-3558. The form asks only for your name, phone, and email. Keep medical details for the visit.

This journal note is educational. Telehealth for Florida patients only. It does not collect medical details, and it is not for emergencies. Call 911 in a crisis.